Literature DB >> 23764014

Aortic valve dysfunction and aortic dilation in adults with coarctation of the aorta.

Mathieu Clair1, Susan M Fernandes, Paul Khairy, Dionne A Graham, Eric V Krieger, Alexander R Opotowsky, Michael N Singh, Steven D Colan, Erik J Meijboom, Michael J Landzberg.   

Abstract

OBJECTIVES: To determine the prevalence of aortic valve dysfunction, aortic dilation, and aortic valve and ascending aortic intervention in adults with coarctation of the aorta (CoA).
BACKGROUND: Aortic valve dysfunction and aortic dilation are rare among children and adolescents with CoA. With longer follow-up, adults may be more likely to have progressive disease.
METHODS: We retrospectively reviewed all adults with CoA, repaired or unrepaired, seen at our center between 2004 and 2010.
RESULTS: Two hundred sixteen adults (56.0% male) with CoA were identified. Median age at last evaluation was 28.3 (range 18.0 to 75.3) years. Bicuspid aortic valve (BAV) was present in 65.7%. At last follow-up, 3.2% had moderate or severe aortic stenosis, and 3.7% had moderate or severe aortic regurgitation. Dilation of the aortic root or ascending aorta was present in 28.0% and 41.6% of patients, respectively. Moderate or severe aortic root or ascending aortic dilation (z-score > 4) was present in 8.2% and 13.7%, respectively. Patients with BAV were more likely to have moderate or severe ascending aortic dilation compared with those without BAV (19.5% vs. 0%; P < 0.001). Age was associated with ascending aortic dilation (P = 0.04). At most recent follow-up, 5.6% had undergone aortic valve intervention, and 3.2% had aortic root or ascending aortic replacement.
CONCLUSION: In adults with CoA, significant aortic valve dysfunction and interventions during early adulthood were uncommon. However, aortic dilation was prevalent, especially of the ascending aorta, in patients with BAV.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Aortic Dilation; Aortic Valve Dysfunction; Bicuspid Aortic Valve; Coarctation of the Aorta

Mesh:

Year:  2013        PMID: 23764014     DOI: 10.1111/chd.12109

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  6 in total

Review 1.  [Anesthesia in children and adolescents with congenital heart defects].

Authors:  T Baehner; O Boehm; M Kliemann; I Heinze; J Breuer; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2015-06       Impact factor: 1.041

2.  Predictors of aortic dilation in patients with coarctation of the aorta: evaluation with dual-source computed tomography.

Authors:  Qin Zhao; Ke Shi; Zhi-Gang Yang; Kai-Yue Diao; Hua-Yan Xu; Xi Liu; Ying-Kun Guo
Journal:  BMC Cardiovasc Disord       Date:  2018-06-22       Impact factor: 2.298

3.  Three Stage Hybrid Approach for Congenital Aortic Coarctation and Bicuspid Aortic Valve With Severe Aortic Stenosis in an Adult Patient.

Authors:  Monica M Matsumoto; Ross Milner
Journal:  EJVES Short Rep       Date:  2019-11-12

4.  Long-term observation of adults after successful repair of aortic coarctation.

Authors:  Beata Róg; Magdalena Okólska; Piotr Weryński; Piotr Wilkołek; Tomasz Pawelec; Jacek Pająk; Piotr Podolec; Lidia Tomkiewicz-Pająk
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-12-08       Impact factor: 1.426

5.  Aortic morphological variability in patients with bicuspid aortic valve and aortic coarctation.

Authors:  Froso Sophocleous; Benedetta Biffi; Elena Giulia Milano; Jan Bruse; Massimo Caputo; Cha Rajakaruna; Silvia Schievano; Costanza Emanueli; Chiara Bucciarelli-Ducci; Giovanni Biglino
Journal:  Eur J Cardiothorac Surg       Date:  2019-04-01       Impact factor: 4.191

6.  Determinants of aortic growth rate in patients with bicuspid aortic valve by cardiovascular magnetic resonance.

Authors:  Froso Sophocleous; Bostjan Berlot; Maria Victoria Ordonez; Mai Baquedano; Elena Giulia Milano; Viola De Francesco; Graham Stuart; Massimo Caputo; Chiara Bucciarelli-Ducci; Giovanni Biglino
Journal:  Open Heart       Date:  2019-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.